Opportunity Information: Apply for PA 16 102
Apply for PA 16 102
- The HHS-NIH11 in the health, income security and social services sector is offering a public funding opportunity titled "Multidisciplinary Research in Vulvodynia (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865,.
- This funding opportunity was created on Feb 18, 2016 and posted on Feb 18, 2016.
- Applicants must submit their applications by May 07, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Multidisciplinary Research in Vulvodynia (R01) funding opportunity (PA-16-102) is a National Institutes of Health (NIH) research grant announcement from HHS/NIH focused on vulvodynia, commonly described as chronic vulvar pain with no clearly identified cause. The announcement signals NIH's continued interest in making vulvodynia a sustained, core area of research and is meant to increase the number and quality of studies that can clarify why the condition occurs, how it can be prevented, how it should be diagnosed, and what treatments work best. A central theme of the opportunity is the encouragement of multidisciplinary and interdisciplinary research, meaning projects are expected to benefit from teams that span multiple fields (for example, gynecology, pain medicine, neurology, immunology, physical therapy, psychology, epidemiology, genetics, and data science) to move the science forward more quickly than single-discipline approaches.
This opportunity uses the NIH R01 mechanism, which is the standard, investigator-initiated research project grant designed to support well-developed, hypothesis-driven (or otherwise strongly justified) research programs. While the source text does not specify a funding cap or number of awards, the emphasis is on supporting substantive research projects that can materially advance understanding of vulvodynia across the full pipeline from causes and risk factors through clinical management and therapeutics. The core research areas highlighted include etiology (identifying biological, neurological, psychological, and/or environmental mechanisms contributing to chronic vulvar pain), prevention (recognizing modifiable risks and early interventions that could reduce incidence or progression), diagnosis (improving measurement, classification, and clinical identification, potentially including biomarkers or better phenotyping), and therapeutics (testing or developing treatments, alone or in combination, and determining which subgroups benefit from which approaches).
Eligibility for applicant organizations is broad, reflecting NIH's intent to draw ideas from many sectors capable of conducting rigorous biomedical and behavioral research. Eligible applicants include various levels of government (state, county, city/township, and special districts), public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, independent school districts, public housing authorities/Indian housing authorities, and Native American tribal governments and tribal organizations (including federally recognized tribes and other eligible tribal entities). The listing is consistent with NIH's general approach of allowing a wide range of research-capable institutions to apply, provided they can meet the scientific, administrative, and compliance requirements of an NIH grant.
Administratively, this is categorized as a discretionary grant in the Health, Income Security and Social Services area, and it is associated with CFDA numbers 93.865 (and also listed with that value in the source). The opportunity was posted on February 18, 2016, with a listed closing date of May 7, 2019. In practical terms, this FOA served as a formal invitation during that period for investigators to submit R01 applications aligned with the stated vulvodynia research priorities, with particular weight placed on projects that integrate multiple disciplines and perspectives to address a complex, poorly understood pain condition that has significant quality-of-life impacts.
FAQs: Multidisciplinary Research in Vulvodynia (R01) (PA-16-102)
What is the Multidisciplinary Research in Vulvodynia (R01) funding opportunity?
It is a National Institutes of Health (NIH) research grant announcement from HHS/NIH titled "Multidisciplinary Research in Vulvodynia (R01)" with funding opportunity number PA-16-102. It supports research on vulvodynia, commonly described as chronic vulvar pain with no clearly identified cause.
What is the main purpose of this NIH announcement?
The purpose is to increase the number and quality of research studies that can clarify why vulvodynia occurs, how it can be prevented, how it should be diagnosed, and what treatments work best. The announcement also signals NIH's intent to keep vulvodynia as a sustained, core area of research.
What is vulvodynia as described in this opportunity?
Vulvodynia is described as chronic vulvar pain with no clearly identified cause.
What research topics does the opportunity prioritize?
The opportunity highlights four core research areas: etiology (causes and mechanisms), prevention (modifiable risks and early interventions), diagnosis (measurement and clinical identification), and therapeutics (treatments and which subgroups benefit).
What types of etiological (cause-and-mechanism) research are relevant here?
Research aimed at identifying biological, neurological, psychological, and/or environmental mechanisms that contribute to chronic vulvar pain is specifically called out as part of the etiology focus.
What kinds of prevention research fit this FOA?
Projects that recognize modifiable risk factors and explore early interventions that could reduce the incidence of vulvodynia or prevent progression are aligned with the prevention emphasis.
What kinds of diagnosis-focused research are encouraged?
The FOA encourages work to improve measurement, classification, and clinical identification of vulvodynia. This may include efforts involving biomarkers or better phenotyping, as noted in the description.
What kinds of therapeutics research are within scope?
The therapeutics scope includes testing or developing treatments, either alone or in combination, and determining which patient subgroups benefit from which approaches.
Does the opportunity encourage multidisciplinary or interdisciplinary teams?
Yes. A central theme is multidisciplinary and interdisciplinary research. The FOA explicitly emphasizes that projects are expected to benefit from teams spanning multiple fields to move the science forward faster than single-discipline approaches.
Which disciplines are mentioned as examples for team composition?
Examples include gynecology, pain medicine, neurology, immunology, physical therapy, psychology, epidemiology, genetics, and data science.
What grant mechanism does this opportunity use?
This opportunity uses the NIH R01 mechanism, which is the standard investigator-initiated research project grant designed to support well-developed, hypothesis-driven (or otherwise strongly justified) research programs.
Is the R01 expected to support substantive projects?
Yes. While the provided information does not list a funding cap or number of awards, it emphasizes supporting substantive research projects that can materially advance understanding of vulvodynia across the pipeline from causes and risk factors through clinical management and therapeutics.
Does the provided information state a funding cap or number of awards?
No. The source information notes that it does not specify a funding cap or the number of awards.
Who can apply for this grant (what organizations are eligible)?
Eligibility is broad. Eligible applicants include various levels of government (state, county, city/township, and special districts), public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, independent school districts, public housing authorities/Indian housing authorities, and Native American tribal governments and tribal organizations (including federally recognized tribes and other eligible tribal entities).
Are nonprofits eligible to apply?
Yes. Both 501(c)(3) nonprofits and non-501(c)(3) nonprofits are listed as eligible applicants.
Are for-profit organizations eligible to apply?
Yes. For-profit organizations (other than small businesses) are listed as eligible, and small businesses are also listed separately as eligible.
Are higher education institutions eligible?
Yes. Both public/state-controlled institutions of higher education and private institutions of higher education are listed as eligible.
Are tribal governments and tribal organizations eligible?
Yes. Native American tribal governments and tribal organizations are listed as eligible, including federally recognized tribes and other eligible tribal entities.
Are government entities eligible to apply?
Yes. The eligibility list includes state governments, county governments, city or township governments, and special district governments.
How is this grant categorized administratively?
It is categorized as a discretionary grant in the Health, Income Security and Social Services area.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.865 (and it is also listed with that value in the provided information).
When was the opportunity posted?
The opportunity was posted on February 18, 2016.
What is the listed closing date?
The listed closing date is May 7, 2019.
What is the overall scientific approach NIH is trying to promote through this FOA?
The FOA promotes integrated, team-based research that combines multiple perspectives and methods to address a complex, poorly understood pain condition with significant quality-of-life impacts, spanning the full research pipeline from underlying causes through clinical management and treatment.
Browse more opportunities from the same category: Health, Income Security and Social Services
Next opportunity: NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15)
Previous opportunity: BLM CO - Vegetation Management and Fuels Reduction.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 16 102
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 16 102) also looked into and applied for these:
| Funding Opportunity |
|---|
| Multidisciplinary Research in Vulvodynia (R03) Apply for PA 16 101 Funding Number: PA 16 101 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Multidisciplinary Research in Vulvodynia (R21) Apply for PA 16 100 Funding Number: PA 16 100 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Rapid Assessment of Zika Virus (ZIKV) Complications (R21) Apply for PAR 16 106 Funding Number: PAR 16 106 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Team-Based Design in Biomedical Engineering Education (R25) Apply for PAR 16 108 Funding Number: PAR 16 108 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $40,000 |
| Spermatogenic Stem Cell Culture Systems to Preserve and Restore Reproductive Capacity in Males (R01) Apply for PAR 16 114 Funding Number: PAR 16 114 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $300,000 |
| Learning Disabilities Innovation Hubs (P20) Apply for RFA HD 17 003 Funding Number: RFA HD 17 003 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $430,000 |
| Archiving and Documenting Child Health and Human Development Data Sets (R03) Apply for PAR 16 149 Funding Number: PAR 16 149 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Animal-Assisted Interventions for Special Populations (R21) Apply for RFA HD 17 015 Funding Number: RFA HD 17 015 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Animal-Assisted Interventions for Special Populations (R03) Apply for RFA HD 17 014 Funding Number: RFA HD 17 014 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21) Apply for PAR 16 195 Funding Number: PAR 16 195 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01) Apply for PAR 16 196 Funding Number: PAR 16 196 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03) Apply for PAR 16 197 Funding Number: PAR 16 197 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) Apply for PAR 16 215 Funding Number: PAR 16 215 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities (R01) Apply for PAR 16 216 Funding Number: PAR 16 216 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Global Network for Womens and Childrens Health Research Data Coordinating Center (U24) Apply for RFA HD 17 010 Funding Number: RFA HD 17 010 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $1,300,000 |
| Understanding STI Co-Infection In At Risk and HIV Infected Adolescents and Young Adults (R01) Apply for RFA HD 17 011 Funding Number: RFA HD 17 011 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $300,000 |
| Characterization of the Adolescent Reproductive Transition (R01) Apply for PA 16 314 Funding Number: PA 16 314 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03) Apply for PA 16 313 Funding Number: PA 16 313 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01) Apply for PA 16 311 Funding Number: PA 16 311 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Characterization of the Adolescent Reproductive Transition (R03) Apply for PA 16 316 Funding Number: PA 16 316 Agency: HHS-NIH11 Category: Health, Income Security and Social Services Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 16 102", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.